Discover how CIBINQO works to fight moderate-to-severe eczema

CIBINQO is a different kind of eczema treatment called a JAK inhibitor. It is approved for people 12 years and older with moderate-to-severe eczema who didn't respond to previous treatment and when other treatments, including oral or injected medicines, haven't worked well or are not right for them.

CIBINQO disrupts a process that can lead to inflammation and itch

Eczema can show up as intensely itchy, scaly or discolored rashes you see and feel on the surface of the skin. But let's take a closer look at what may be happening under the surface, where CIBINQO works to help fight eczema.

what causes eczema


Eczema may occur because of irregular immune responses that take place within the body.

Some proteins that play a role in this overactive immune response are called JAKs. Increased JAK activity is thought to contribute to your skin becoming inflamed.

how does CIBINQO™ (abrocitinib) work


CIBINQO is a type of eczema treatment known as a JAK inhibitor. It blocks JAK1 activity, interrupting one of the processes that leads to inflammation.

how does CIBINQO™ (abrocitinib) work


Less inflammation can mean less itch and clearer skin.

It's not currently known how inhibiting specific JAK proteins can affect eczema.

Looking for proven eczema relief?

See how CIBINQO helped provide clearer skin and itch relief for some people (ages 12 years and older) in clinical trials.

Show the results

Teen study results

Connect with a nearby doctor

Schedule an appointment with your doctor today. If you don’t have one yet, you can find one using this tool.

Find a doctor